POU1F1: A Drug Target / Disease Biomarker (G5449)

Target Name: POU1F1

NCBI ID: G5449

POU1F1: A Drug Target / Disease Biomarker

POU1F1, also known as protamineuron, is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a transmembrane protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

Studies have shown that POU1F1 is involved in the production of dopamine in the brain and that it is a potential drug target for the treatment of neurological disorders. POU1F1 has been shown to be involved in the development of Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a transmembrane protein that is involved in the production of dopamine in the brain. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a transmembrane protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a potential drug target for the treatment of various neurological disorders, including Parkinson's disease, Alzheimer's disease, and addiction.

POU1F1 is a protein that is expressed in the brain and is involved in the production of dopamine. It is a key regulator of dopamine release and plays a role in the development and progression of neurodegenerative disorders.

POU1F1 is

Protein Name: POU Class 1 Homeobox 1

Functions: Transcription factor involved in the specification of the lactotrope, somatotrope, and thyrotrope phenotypes in the developing anterior pituitary. Specifically binds to the consensus sequence 5'-TAAAT-3'. Activates growth hormone and prolactin genes (PubMed:22010633, PubMed:26612202)

More Common Targets